|Articles|May 30, 2019
Speaking with David Van Sickle, CEO, Propeller Health
David Van Sickle, CEO, Propeller Health, talks with Pharm Exec's European Editor, Julian Upton, at the 2019 17th Annual Patient Engagement eyeforpharma Barcelona event about how the digital therapeutics landscape has changed.
Advertisement
David Van Sickle, CEO, Propeller Health, talks with Pharm Exec's European Editor, Julian Upton, at the 2019 17th Annual Patient Engagement eyeforpharma Barcelona event about how the digital therapeutics landscape has changed.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement
2
Aradhana Sarin: The CFO as a Catalyst
3
Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report
4
Lipid Lowering with PCSK9 Inhibition: Long-Term Efficacy, Long-Standing Barriers
5